Literature DB >> 6753681

Cimetidine: II. Adverse reactions and patterns of use.

J W Freston.   

Abstract

Numerous adverse reactions have been attributed to cimetidine, which is understandable in view of the attention and scrutiny the drug has received, its widespread use, and its systemic effects. The reported frequency of side effects has differed considerably but is surprisingly low in all studies. The drug has caused an array of central nervous system disturbances, gynecomastia, and, rarely, hepatotoxicity, interstitial nephritis, bradycardia, hypotension, and even cardiac arrest. The last complication has occurred with rapid-bolus intravenous injection. Blood dyscrasias have also been rare and usually associated with serious underlying disease or multiple drugs, making it difficult to establish cause and effect in most cases. The drug is used widely to treatment conditions for which it is not approved. Some of these conditions are now believed to respond to cimetidine (gastric ulcer); others are known not to respond (acute upper gastrointestinal bleeding and acute pancreatitis).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753681     DOI: 10.7326/0003-4819-97-5-728

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

1.  The use of cimetidine in hospitalized patients.

Authors:  L Kopala
Journal:  Can Fam Physician       Date:  1984-01       Impact factor: 3.275

2.  Peptic ulcer disease. Pathophysiology and current medical management.

Authors:  B F Scharschmidt
Journal:  West J Med       Date:  1987-06

Review 3.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Authors:  Jeong Soo Ahn; Chun-Sick Eom; Christie Y Jeon; Sang Min Park
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

5.  Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.

Authors:  S K Dutta; V S Hubbard; M Appler
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

6.  Prolonged cholestasis and cimetidine.

Authors:  B Clarke; A Yoong
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

7.  The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits.

Authors:  N L Harris; D E Brenner; L B Anthony; J C Collins; S Halter; K R Hande
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  The comparative efficacy of cimetidine and ranitidine in controlling gastric pH in critically ill patients.

Authors:  S R Reid; C D Bayliff
Journal:  Can Anaesth Soc J       Date:  1986-05

9.  Short term treatment of gastric ulcer: a comparison of sucralfate and cimetidine.

Authors:  B Hallerbäck; O Anker-Hansen; L Carling; H Glise; J H Solhaug; L E Svedberg; L Wählby
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

10.  Effects of cimetidine on drug metabolism in rat pups.

Authors:  C O Ikediobi; H O Kwanashie; G Osuide; C Wambebe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.